What is the share price of Nath Bio-Genes (I) Ltd (NATHBIOGEN) today?
The share price of NATHBIOGEN as on 17th June 2025 is ₹207.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Nath Bio-Genes (I) Ltd (NATHBIOGEN) share?
The past returns of Nath Bio-Genes (I) Ltd (NATHBIOGEN) share are- Past 1 week: 5.61%
- Past 1 month: 9.00%
- Past 3 months: 42.46%
- Past 6 months: 5.45%
- Past 1 year: 4.05%
- Past 3 years: 26.88%
- Past 5 years: -39.44%
What are the peers or stocks similar to Nath Bio-Genes (I) Ltd (NATHBIOGEN)?
The peers or stocks similar to Nath Bio-Genes (I) Ltd (NATHBIOGEN) include:What is the dividend yield % of Nath Bio-Genes (I) Ltd (NATHBIOGEN) share?
The current dividend yield of Nath Bio-Genes (I) Ltd (NATHBIOGEN) is 0.98.What is the market cap of Nath Bio-Genes (I) Ltd (NATHBIOGEN) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nath Bio-Genes (I) Ltd (NATHBIOGEN) is ₹386.28 Cr as of 17th June 2025.What is the 52 week high and low of Nath Bio-Genes (I) Ltd (NATHBIOGEN) share?
The 52-week high of Nath Bio-Genes (I) Ltd (NATHBIOGEN) is ₹264.31 and the 52-week low is ₹137.55.What is the PE and PB ratio of Nath Bio-Genes (I) Ltd (NATHBIOGEN) stock?
The P/E (price-to-earnings) ratio of Nath Bio-Genes (I) Ltd (NATHBIOGEN) is 10.01. The P/B (price-to-book) ratio is 0.63.Which sector does Nath Bio-Genes (I) Ltd (NATHBIOGEN) belong to?
Nath Bio-Genes (I) Ltd (NATHBIOGEN) belongs to the Consumer Staples sector & Agro Products sub-sector.How to buy Nath Bio-Genes (I) Ltd (NATHBIOGEN) shares?
You can directly buy Nath Bio-Genes (I) Ltd (NATHBIOGEN) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Nath Bio-Genes (I) Ltd
NATHBIOGEN Share Price
207.201.94% (+3.94)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
NATHBIOGEN Performance & Key Metrics
NATHBIOGEN Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 10.01 | 0.63 | 0.98% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.55 | 9.22 | 1.70% |
NATHBIOGEN Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
NATHBIOGEN Company Profile
Nath Bio-Genes (India) is engaged in hybrid seed business and production, processing and marketing of hybrid and genetically modified (GM) seeds
GODREJAGRO
PE Ratio
34.65
34.65
1Y Return
27.68%
27.68%
Buy Reco %
83.33
83.33
PE Ratio
21.33
21.33
1Y Return
18.55%
18.55%
Buy Reco %
100.00
100.00
PE Ratio
29.01
29.01
1Y Return
9.45%
9.45%
Buy Reco %
0.00
0.00
BNHOLDINGS
PE Ratio
92.90
92.90
1Y Return
24.31%
24.31%
Buy Reco %
0.00
0.00
SANSTAR
PE Ratio
37.65
37.65
1Y Return
21.73%
21.73%
Buy Reco %
0.00
0.00
NATHBIOGEN Sentiment Analysis
NATHBIOGEN Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
NATHBIOGEN Stock Summary · May 2025
In FY '25, the company showcased resilience through significant growth in its non-cotton and non-paddy segments, particularly in bajra, maize, and vegetable seeds, while also expanding internationally into markets like the Philippines and Uzbekistan. Despite modest EBITDA growth due to necessary investments, management remains optimistic, targeting INR 500 crores in sales and a long-term goal of INR 1,000 crores. Enhanced infrastructure and operational readiness position the company well for the upcoming market season, even as challenges in the cotton market persist. A strategic focus on research and development, alongside improved working capital management, underscores a commitment to innovation and competitive differentiation, paving the way for sustained growth amidst evolving market dynamics.
NATHBIOGEN Stock Growth Drivers
NATHBIOGEN Stock Growth Drivers
6Strong Financial Performance
Nath Bio-Genes has reported solid growth in its non-cotton, non-paddy portfolio, which has become a
Product Innovation and Diversification
The company has expanded its product portfolio with the introduction of new biotonic products aimed
NATHBIOGEN Stock Challenges
NATHBIOGEN Stock Challenges
5Decline in Paddy Volumes
The company has reported a minor year-over-year decline in paddy volumes, with figures showing a
Decreased Recoveries from Provisions
There has been a significant decrease in recoveries from provisions made in previous years, dropping
NATHBIOGEN Forecast
NATHBIOGEN Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
NATHBIOGEN
NATHBIOGEN
Income
Balance Sheet
Cash Flow
Annual Normal View
NATHBIOGEN Income Statement
NATHBIOGEN Income Statement
Annual Normal View
| Financial Year | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 280.21 | 301.91 | 336.70 | 369.99 | 370.00 | |||||
Raw Materials | 3.56 | 5.31 | 12.26 | 315.11 | 315.11 | |||||
| Power & Fuel Cost | 1.07 | 1.39 | 1.13 | |||||||
| Employee Cost | 24.78 | 23.32 | 27.58 | |||||||
| Selling & Administrative Expenses | 89.99 | 112.25 | 139.47 | |||||||
| Operating & Other expenses | 210.53 | 110.26 | 102.23 | |||||||
EBITDA | -49.72 | 49.38 | 54.03 | 54.88 | 54.89 | |||||
| Depreciation/Amortization | 3.08 | 3.01 | 3.26 | 3.82 | 3.83 | |||||
| PBIT | -52.80 | 46.37 | 50.77 | 51.06 | 51.06 | |||||
| Interest & Other Items | 10.64 | 10.21 | 9.20 | 10.48 | 10.49 | |||||
| PBT | -63.44 | 36.16 | 41.57 | 40.58 | 40.57 | |||||
| Taxes & Other Items | 3.95 | 1.13 | 1.95 | 1.98 | 1.99 | |||||
| Net Income | -67.39 | 35.03 | 39.62 | 38.60 | 38.58 | |||||
| EPS | -35.46 | 18.43 | 20.85 | 20.14 | 20.30 | |||||
| DPS | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | |||||
| Payout ratio | — | 0.11 | 0.10 | 0.10 | 0.10 |
NATHBIOGEN Company Updates
NATHBIOGEN Stock Peers
NATHBIOGEN Past Performance & Peer Comparison
NATHBIOGEN Past Performance & Peer Comparison
Comparing 3 stocks from
Consumer StaplesAgro Products
Compare valuation on Screener
Consumer StaplesAgro Products
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Nath Bio-Genes (I) Ltd | 10.01 | 0.63 | 0.98% |
| Godrej Agrovet Ltd | 34.65 | 5.10 | 1.42% |
| Gujarat Ambuja Exports Ltd | 21.33 | 1.92 | 0.22% |
| Jubilant Agri and Consumer Products Ltd | 29.01 | 11.07 | — |
NATHBIOGEN Stock Price Comparison
Compare NATHBIOGEN with any stock or ETFCompare NATHBIOGEN with any stock or ETF
NATHBIOGEN
NATHBIOGEN Holdings
NATHBIOGEN Shareholdings
NATHBIOGEN Promoter Holdings Trend
NATHBIOGEN Promoter Holdings Trend
NATHBIOGEN Institutional Holdings Trend
NATHBIOGEN Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
NATHBIOGEN Shareholding Pattern
NATHBIOGEN Shareholding Pattern
NATHBIOGEN Shareholding History
NATHBIOGEN Shareholding History
Foreign Institutions
Mutual Funds Invested in NATHBIOGEN
Mutual Funds Invested in NATHBIOGEN
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 1 Mutual Funds holding Nath Bio-Genes (I) Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.3262% | Percentage of the fund’s portfolio invested in the stock 0.15% | Change in the portfolio weight of the stock over the last 3 months -0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 39/88 (-2) |
Compare 3-month MF holding change on Screener
smallcases containing NATHBIOGEN stock
smallcases containing NATHBIOGEN stock
Looks like this stock is not in any smallcase yet.
NATHBIOGEN Events
NATHBIOGEN Events
NATHBIOGEN Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
NATHBIOGEN Dividend Trend
No dividend trend available
NATHBIOGEN Upcoming Dividends
NATHBIOGEN Upcoming Dividends
No upcoming dividends are available
NATHBIOGEN Past Dividends
NATHBIOGEN Past Dividends
Cash Dividend
Ex DateEx DateAug 9, 2024
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Aug 9, 2024
Cash Dividend
Ex DateEx DateJul 4, 2023
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Jul 4, 2023
Cash Dividend
Ex DateEx DateJun 23, 2022
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Jun 23, 2022
Cash Dividend
Ex DateEx DateAug 18, 2021
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Aug 18, 2021
NATHBIOGEN Stock News & Opinions
NATHBIOGEN Stock News & Opinions
Articles & Videos
Corporate
Nath Bio-Genes (India) to convene AGM
Nath Bio-Genes (India) announced that the 32th Annual General Meeting(AGM) of the company will be held on 22 August 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Nath Bio-Genes (India) recommends final dividend
Nath Bio-Genes (India) announced that the Board of Directors of the Company at its meeting held on 29 April 2025, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 20%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Nath Bio-Genes (India) consolidated net profit declines 43.51% in the March 2025 quarter
Net profit of Nath Bio-Genes (India) declined 43.51% to Rs 1.48 crore in the quarter ended March 2025 as against Rs 2.62 crore during the previous quarter ended March 2024. Sales rose 20.75% to Rs 51.97 crore in the quarter ended March 2025 as against Rs 43.04 crore during the previous quarter ended March 2024. For the full year,net profit declined 2.57% to Rs 38.60 crore in the year ended March 2025 as against Rs 39.62 crore during the previous year ended March 2024. Sales rose 9.71% to Rs 364.91 crore in the year ended March 2025 as against Rs 332.62 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales51.9743.04 21 364.91332.62 10 OPM %0.819.13 -13.6414.99 - PBDT2.913.27 -11 43.8641.38 6 PBT1.572.28 -31 40.0438.11 5 NP1.482.62 -44 38.6039.62 -3 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Nath Bio-Genes (India) to table results
Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 29 April 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Nath Bio-Genes (India) consolidated net profit declines 30.81% in the December 2024 quarter
Net profit of Nath Bio-Genes (India) declined 30.81% to Rs 2.65 crore in the quarter ended December 2024 as against Rs 3.83 crore during the previous quarter ended December 2023. Sales rose 16.16% to Rs 36.87 crore in the quarter ended December 2024 as against Rs 31.74 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales36.8731.74 16 OPM %21.7817.77 - PBDT4.622.85 62 PBT3.792.09 81 NP2.653.83 -31 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Nath Bio-Genes (India) to convene board meeting
Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 23 January 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Nath Bio-Genes (India) consolidated net profit declines 26.49% in the September 2024 quarter
Net profit of Nath Bio-Genes (India) declined 26.49% to Rs 1.11 crore in the quarter ended September 2024 as against Rs 1.51 crore during the previous quarter ended September 2023. Sales rose 42.62% to Rs 32.19 crore in the quarter ended September 2024 as against Rs 22.57 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.1922.57 43 OPM %14.9422.06 - PBDT1.912.61 -27 PBT1.091.85 -41 NP1.111.51 -26 Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Nath Bio-Genes (India) standalone net profit rises 79.50% in the September 2024 quarter
Net profit of Nath Bio-Genes (India) rose 79.50% to Rs 2.89 crore in the quarter ended September 2024 as against Rs 1.61 crore during the previous quarter ended September 2023. Sales rose 42.62% to Rs 32.19 crore in the quarter ended September 2024 as against Rs 22.57 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.1922.57 43 OPM %20.3822.60 - PBDT3.692.72 36 PBT2.861.96 46 NP2.891.61 80 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Nath Bio-Genes (India) announces board meeting date
Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 23 October 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Nath Bio-Genes (India) consolidated net profit declines 0.24% in the June 2024 quarter
Net profit of Nath Bio-Genes (India) declined 0.24% to Rs 33.35 crore in the quarter ended June 2024 as against Rs 33.43 crore during the previous quarter ended June 2023. Sales rose 3.66% to Rs 243.88 crore in the quarter ended June 2024 as against Rs 235.28 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales243.88235.28 4 OPM %14.9815.74 - PBDT34.4334.38 0 PBT33.6033.62 0 NP33.3533.43 0 Powered by Capital Market - Live
10 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant